Old Drugs Find New Life as Brain Treatments

Developing new drugs is no easy feat. As much as 95 percent of new compounds fail along the path to becoming clinically available. Attrition is especially high for drugs treating the central nervous system. The ones that do succeed rack up an average cost of $1.8 billion. So researchers are increasingly turning to the bottles already on the shelf. Proved safe for human consumption and often understood at a molecular level, today's familiar pills might just be tomorrow's medical discovery. Sometimes one man's side effect is another man's cure.

iSTOCKPHOTO (people); SVETLANA ALYUK iStockphoto (mice)

Rights & Permissions

This article was originally published with the title "Old Drugs, New Tricks."

or subscribe to access other articles from the March 2013 publication.
Digital Issue $7.95
Digital Subscription $19.99 Subscribe
Share this Article:


You must sign in or register as a member to submit a comment.

Email this Article